Study Of Stubborn Breast Cancers: Group Seeks To Turn Genomic Medicine To Resistant Tumors

Life Technologies said Friday it is applying its gene sequencing prowess to a challenging project: detecting genetic information about breast cancers that show no sign of obvious mutations linked with the disease. Source: General Cancer News Articles Provided by Cancer Compass

  • Share/Bookmark

Leave a Reply